This Quarterly Report on Form
10-Q
includes forward-looking statements. These forward-looking statements are based
on our current expectations and beliefs concerning future developments and their
potential effects on us. There can be no assurance that future developments
affecting us will be those that we have anticipated. These forward-looking
statements involve a number of risks, uncertainties (some of which are beyond
our control) or other assumptions that may cause actual results or performance
to be materially different from those expressed or

                                       18

--------------------------------------------------------------------------------

Table of Contents

implied by these forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management team's expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Factors that might cause or contribute to such forward-looking statements include, but are not limited to, those set forth in the Risk Factors section of the Company's registration statement and prospectus for the Company's offering filed with the SEC. The following discussion should be read in conjunction with our unaudited condensed financial statements and related notes thereto included elsewhere in this report.

Overview

We are a blank check company incorporated on April 22, 2021 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a "Business Combination"). We consummated our Public Offering (as defined below) on September 24, 2021 and are currently in the process of locating suitable targets for our initial Business Combination. We intend to use the cash proceeds from our Public Offering and the Private Placement described below as well as additional issuances, if any, of our capital stock, debt or a combination of cash, stock and debt to complete the Business Combination.

We expect to incur significant costs in the pursuit of our initial Business Combination. We cannot assure you that our plans to raise capital or to complete our initial Business Combination will be successful.

Liquidity and Capital Resources


On September 24, 2021, the Company consummated its $304,750,000 Public Offering
consisting of 30,475,000 units at a price of $10.00 per unit ("Unit"). Each Unit
consists of one share of the Company's Class A common stock, $0.0001 par value
(the "Class A Common Stock") and
one-half
of one redeemable warrant (each, a "Public Warrant"). Simultaneously, with the
closing of the Public Offering, the Company consummated a $14,440,000 private
placement ("Private Placement") of an aggregate of 9,626,667 warrants ("Private
Placement Warrants") at a price of $1.50 per warrant. Upon closing of the Public
Offering and Private Placement on September 24, 2021, $310,845,000 in proceeds
(including $10,666,250 of deferred underwriting commissions) from the Public
Offering and Private Placement was placed in a U.S.-based trust account
maintained by Continental Stock Transfer & Trust Company, acting as trustee (the
"Trust Account"). The Company also used funds held outside of the Trust Account
to pay underwriting commissions of $6,095,000 and deferred offering and
formation costs.

For the six months ended June 30, 2022, cash used in operating activities was $976,738. Net income of $18,806,793 was attributable to the change in fair value of warrant liabilities of $8,606,192, gain on settlement of deferred underwriting commissions of $10,666,250, interest earned on marketable securities held in the Trust Account of $806,581 and changes in operating assets and liabilities which provided $295,492 in cash from operating activities.

As of June 30, 2022, the Company had cash and marketable securities held in the Trust Account of $311,684,500. The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete a Business Combination. The Company may withdraw interest to pay franchise and income taxes. Through June 30, 2022, no cash was withdrawn from the Trust Account to pay franchise and income taxes. To the extent that the Company's capital stock or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue its growth strategies.

As of June 30, 2022, the Company had an unrestricted cash balance of $254,030 as well as cash held outside the Trust Account. The Company intends to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.


                                       19

--------------------------------------------------------------------------------

Table of Contents

Further, the Sponsor or an affiliate of the Sponsor or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company will repay such additional loaned amounts, without interest, upon consummation of the Business Combination. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such additional loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such additional loans (if any) are convertible into warrants, at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the private placement warrants, including as to exercise price, exercisability and exercise period. Except for the foregoing, the terms of such additional loans (if any) have not been determined and no written agreements exist with respect to such loans.

If the Company is unable to complete a business combination by March 24, 2023, then the Company will cease all operations except for the purpose of liquidating. In connection with the Company's assessment of going concern considerations in accordance with FASB ASC Topic 205-40, "Presentation of Financial Statements - Going Concern," management has determined that the liquidity condition and mandatory liquidation on March 24, 2023 and subsequent dissolution raises substantial doubt about the Company's ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 24, 2023. Management plans to consummate a Business Combination prior to March 24, 2023, however there can be no assurance that one will be completed.

Results of Operations and Known Trends or Future Events

We have neither engaged in any significant business operations nor generated any revenues to date. All activities to date relate to the Company's formation and the Public Offering (the "Public Offering"). We expect to generate non-operating income in the form of interest income on cash, cash equivalents, and marketable securities that will be held in the Trust Account (as defined below). We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses as we locate a suitable Business Combination.

For the three months ended June 30, 2022, we had a net income of $17,524,004, which consists of interest earned on marketable securities held in the Trust Account of $730,032, the change in fair value of warrant liabilities of $6,865,700, and gain on settlement of deferred underwriting commissions of $10,666,250, offset by operating costs of $603,118 and provision for income taxes of $134,680. For the period from April 22, 2021 to June 30, 2021, there were no activity except for formation costs of $665. For the six months ended June 30, 2022, we had a net income of $18,806,793, which consists of interest earned on marketable securities held in the Trust Account of $806,581, the change in fair value of warrant liabilities of $8,606,192, and gain on settlement of deferred underwriting commissions of $10,666,250, offset by operating costs of $1,137,370 and provision for income taxes of $134,680. Through June 30, 2022 our efforts have been limited to organizational activities, activities relating to the Public Offering, activities relating to identifying and evaluating prospective acquisition candidates and activities relating to general corporate matters. We have not generated any revenue, other than interest income earned on the proceeds held in the Trust Account. As of June 30, 2022, $311,684,500 was held in the Trust Account (including $10,666,250 of deferred underwriting discounts and commissions and approximately $8.9 million from the Private Placement) and we had cash outside of the Trust Account of $254,030 and $1,057,941 in accounts payable and accrued expenses .

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor a monthly fee of $20,000 for office space, utilities and secretarial, and administrative support services to the Company. We began incurring these fees on September 25, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination or the Company's liquidation.

The underwriters were entitled to a deferred fee of $0.35 per Unit, or $10,666,250 in the aggregate, payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In June 2022, the underwriters waived their deferred fee, resulting in a gain from settlement of deferred underwriting commissions of $10,666,250.


                                       20

--------------------------------------------------------------------------------

Table of Contents

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and Warrants that may be issued upon conversion of working capital loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Critical Accounting Policies

The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed financial statements and accompanying notes. Actual results could differ from those estimates. The Company has identified the following as its critical accounting policies:

Warrant Liability


We do not use derivative instruments to hedge exposures to cash flow, market, or
foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to ASC 480
and ASC 815. We account for the Warrants in accordance with the guidance
contained in ASC
815-40
under which the Warrants do not meet the criteria for equity treatment and must
be recorded as liabilities. Accordingly, we classify the Warrants as liabilities
at their fair value and adjust the Warrants to fair value at each reporting
period. This liability is subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is
recognized in our statements of operations. The Private Placement Warrants and
the Public Warrants for periods where no observable traded price was available
are valued using the Black-Scholes option and the Monte Carlo simulation model,
respectively. For periods subsequent to the detachment of the Public Warrants
from the Units, the Public Warrant quoted market price will be used as the fair
value as of each relevant date.

Investments Held in Trust Account

The proceeds held in the trust account (the "Trust Account") were invested in permitted United States "government securities" within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "Investment Company Act"), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations.

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and is measured at redemption value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) is classified as temporary equity. At all other times, common stock is classified as stockholders' equity. The Company's Class A common stock features certain redemption rights that are considered to be outside of the Company's control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders' equity section of the Company's unaudited condensed balance sheets.


                                       21

--------------------------------------------------------------------------------

Table of Contents

Net Income (Loss) Per Share



Net income (loss) per share of common stock is computed by dividing net income
(loss) by the weighted average number of common stock outstanding for the
period. The Company applies the
two-class
method in calculating earnings per share. Accretion associated with the
redeemable shares of Class A common stock is excluded from earnings per share as
the redemption value approximates fair value.

Recent Accounting Pronouncements



In August 2020, the FASB issued Accounting Standards Update ("ASU")
2020-06,
Debt-Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic
815-40)
("ASU
2020-06")
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion
and cash conversion features from convertible instruments and simplifies the
derivative scope exception guidance pertaining to equity classification of
contracts in an entity's own equity. The new standard also introduces additional
disclosures for convertible debt and freestanding instruments that are indexed
to and settled in an entity's own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use
the
if-converted
method for all convertible instruments. ASU
2020-06
is effective January 1, 2024 and should be applied on a full or modified
retrospective basis, with early adoption permitted beginning on January 1, 2021.
The Company is currently assessing the impact, if any, that ASU
2020-06
would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.



Off-Balance
Sheet Arrangement

We did not have any
off-balance
sheet arrangements as of June 30, 2022 as defined in Item 303(a)(4)(ii) of
Regulation
S-K.

© Edgar Online, source Glimpses